Price$2.38+0.06 (+2.81%)
2026-03-052026-06-08
News · 26 weeks5-100%
2025-12-142026-06-07
Mix490d
- SEC Filings4(100%)
Latest news
25 items- SECSEC Form 10-Q filed by XBiotech Inc.10-Q - XBiotech Inc. (0001626878) (Filer)
- SECAmendment: SEC Form 10-K/A filed by XBiotech Inc.10-K/A - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form 10-K filed by XBiotech Inc.10-K - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form S-8 filed by XBiotech Inc.S-8 - XBiotech Inc. (0001626878) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by XBiotech Inc.SCHEDULE 13G/A - XBiotech Inc. (0001626878) (Subject)
- SECXBiotech Inc. filed SEC Form 8-K: Leadership Update8-K - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form 10-Q filed by XBiotech Inc.10-Q - XBiotech Inc. (0001626878) (Filer)
- INSIDERSEC Form 4 filed by Director Rademaker Craig Evan4 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERSEC Form 4 filed by Director Soffer David Spencer4 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERSEC Form 4 filed by Director Kuendig Thomas Martin4 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERSEC Form 4 filed by Director Troy Tevi David4 - XBiotech Inc. (0001626878) (Issuer)
- SECAmendment: XBiotech Inc. filed SEC Form 8-K: Leadership Update8-K/A - XBiotech Inc. (0001626878) (Filer)
- SECXBiotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - XBiotech Inc. (0001626878) (Filer)
- INSIDERSEC Form 3 filed by new insider Soffer David Spencer3 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERNew insider Kuendig Thomas Martin claimed ownership of 300,000 shares (SEC Form 3)3 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERSEC Form 3 filed by new insider Troy Tevi David3 - XBiotech Inc. (0001626878) (Issuer)
- INSIDERNew insider Rademaker Craig Evan claimed ownership of 170,985 shares (SEC Form 3)3 - XBiotech Inc. (0001626878) (Issuer)
- SECXBiotech Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form 10-Q filed by XBiotech Inc.10-Q - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form DEF 14A filed by XBiotech Inc.DEF 14A - XBiotech Inc. (0001626878) (Filer)
- SECXBiotech Inc. filed SEC Form 8-K: Leadership Update8-K - XBiotech Inc. (0001626878) (Filer)
- SECSEC Form 10-Q filed by XBiotech Inc.10-Q - XBiotech Inc. (0001626878) (Filer)
- SECAmendment: SEC Form 10-K/A filed by XBiotech Inc.10-K/A - XBiotech Inc. (0001626878) (Filer)
- SECXBiotech Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - XBiotech Inc. (0001626878) (Filer)
- SECXBiotech Inc. filed SEC Form 8-K: Leadership Update8-K - XBiotech Inc. (0001626878) (Filer)
XBIT FAQ
6 questionsWhat does XBiotech Inc. do?
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and True Human COVID-19 therapy for treating the COVID-19 mutant virus. In addition, the company provides clinical trial contract research operations to conduct two...Where does XBIT stock trade?
XBiotech Inc. (XBIT) is listed on NASDAQ.What sector and industry is XBIT in?
XBiotech Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did XBiotech Inc. go public?
XBiotech Inc. (XBIT) completed its IPO in 2015.What companies are similar to XBIT?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare XBIT side-by-side with any of them on Quantisnow.How can I track XBIT on Quantisnow?
Quantisnow aggregates XBiotech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XBIT to receive live email and push alerts on every new disclosure.